Emyria Ltd has released a press release.
Prospectus
Filed with ASX ·
On 6ix: 6ix.com/news/prospectus-52
6ix hasn’t read this filing yet.
In the deck
Story so far
Earlier from Emyria
- Emyria Gets $2M Bids, Sets $3.1M Entitlement Offer
- Appendix 4E Preliminary Financial Report
- Emyria Launches Ketamine-Assisted Therapy Program
- Emyria advances development and commercialisation of unique drug products
- June 2023 Quarterly Activities Report and Appendix 4C
Later from Emyria
- Strategic Update & Entitlement Offer Presentation
- Emyria provides unique combination of drug development and therapy delivery
- Emyria Completes Acquisition of the Pax Centre
- Emyria Secures Local MDMA to Start PTSD Trial Dosing
- Emyria set to begin MDMA study after securing local supply
Follow Emyria into a list and get an email when it puts out news.
Follow Emyria